Found 13 matching trials
Procedural Advantages of a Novel Drug-Eluting Coronary Stent NA This study sought to compare procedural performance of a new coronary stent...
Show More Location
Multiple Locations
Learn More & Join Trial
EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) PHASE3 The purpose of this study is to evaluate 9 month angiographic and intravasc...
Show More Location
The Prince Charles Hospital
Learn More & Join Trial
A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s) N/A EVOLVE 4.5/5.0 is a prospective, single-arm, multi-center observational (st...
Show More Location
Yale New Haven Hospital
Learn More & Join Trial
Multivessel TALENT NA Multivessel TALENT is a prospective, randomized, multi-center study compari...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Late Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI N/A The purpose of this study is to evaluate the incidence of late incomplete s...
Show More Location
Keimyung University Dongsan Medical Center
Learn More & Join Trial
TRANSFORM OCT TRiple Assessment of Neointima Stent FOrmation to Reabsorbable polyMer With Optical Coherence Tomography PHASE4 First prospective randomized controlled study to evaluate in an 'all-comers...
Show More Location
A.O. Ospedale Papa Giovanni XXIII
Learn More & Join Trial
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) PHASE3 The purpose of this study is to assess the safety and effectiveness of the ...
Show More Location
Baptist Medical Center - Princeton
Learn More & Join Trial
Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry PHASE3 The CLEAR SYNERGY trial will study the long term effects of treatments foll...
Show More Location
Central Cardiology
Learn More & Join Trial
Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction NA To assess strut coverage in patients presenting an acute myocardial infarct...
Show More Learn More & Join Trial
Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimaxâ˘) to the Drug (Everolimus) -Eluting Stent (Synergyâ˘) in Acute Coronary Syndrome PHASE4 The purpose of the prospective, randomized and a multicenter trial is to co...
Show More Location
Heart Center, Helsinki University Hospital
Learn More & Join Trial